Implementation of A New, Mobile Diabetic Retinopathy Screening Model Incorporating Artificial Intelligence in Remote Western Australia

Objective

Diabetic retinopathy (DR) screening rates are poor in remote Western Australia where communities rely on outdated primary care-based retinal cameras. Deep learning systems (DLS) may improve access to screening, however, require validation in real-world settings. This study describes and evaluates the implementation of a new, mobile DR screening model that incorporates artificial intelligence (AI) into routine care.

Design

Prospective, population-based study.

Setting

The model was co-designed with local Aboriginal communities and implemented in the remote, Pilbara region of Western Australia. A research officer without formal healthcare qualification performed retinal screening aboard a Mercedes Sprinter Van using an automated retinal camera with integrated AI diagnostics. Patients received their diagnosis on-the-spot and completed an evaluation survey. A remote clinician provided supervision and on-the-spot telehealth consultation for referable disease.

Participants

People with diabetes from the Pilbara region.

Main Outcome Measure(s)

Number of people screened, acceptability of AI to patients.

Results

From February to August 2024, DR screening was provided to 9 communities across the Pilbara region. 78 patients provided research consent, of which 56.4% were Aboriginal or Torres Strait Islanders. 10.3% of retinal photos had referable DR and 8.4% of photos were ungradable. 96% of patients were ‘Happy with the use of AI’.

Conclusion

Our new model for AI-assisted DR screening was culturally safe, acceptable to patients and effective, demonstrating an 11-fold increase in screening rates compared to 2023 Pilbara data. In remote Australian settings, AI-assisted DR screening may overcome historical barriers to service provision and improve minimisation of preventable blindness.